NCT07162194

MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial

SUSPENDEDNAINTERVENTIONAL

Trial Details

Start: 2025-09-19Est. Completion: 2027-10-15

Enrollment target: 130 participants

Locations

USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Other microbiome trials you might be interested in

Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand TherapyPhase 1Recruiting

Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IVA Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8

This clinical trial studies mechanisms of resistance to 177-lutetium prostate specific membrane antigen (177Lu-PSMA) rad…

Los Angeles, United StatesEst. completion Dec 31, 2026

View Trial →

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung CancerPhase 3Recruiting

Recurrent Lung Non-Small Cell Carcinoma

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.